Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Survival
data OK for cancer drug Velcade's label 4:03 AM 1/5/2010
Reuters
Takeda Pharmaceutical Co's data from a clinical trial showed a 35 percent reduction in
the risk of death for patients who took Velcade compared to the standard treatments of melphalan and
prednisone.
Elusys
could get $143M in anthrax treatment funds 12:43 PM 1/4/2010
BusinessWeek
Elusys Therapeutics Inc said it will receive $16.8 million in its first year with
options for more funding to develop, manufacture, and license Anthim as a treatment for inhaled anthrax.
...
Dr
Reddy's: Balaglitazone Drug Meets Primary Endpoint In Phase III
Study 7:58 AM 1/4/2010
Wall Street
Journal
Dr Reddy’s Laboratories and Rheoscience announced results from the first phase III study for
their investigational agent balaglitazone. The trial met its primary endpoint of reduction in HbA1c.
...
Cipher
to seek US approval for pain treatment 7:33 AM 1/4/2010
Reuters
Canada's Cipher Pharmaceuticals said it will seek final approval for its CIP-tramadol
extended-release pain treatment after winning a US patent dispute.
...
InterMune
gets FDA priority review for pirfenidone 6:45 AM 1/4/2010
MarketWatch
InterMune Inc said its new drug application for idiopathic pulmonary fibrosis
treatment pirfenidone has been granted priority review from the US FDA.
...
Novartis
seeks full ownership of eyecare giant Alcon 5:55 AM 1/4/2010
AFP
Novartis said it had bought a controlling stake in eye-care giant Alcon from Nestle and
that it was seeking full ownership.
...
Evolva,
Roche agree cancer drug research deal 5:11 AM 1/4/2010
Reuters
Swiss biotech Evolva agreed to collaborate with Roche Holdings to develop new
anti-cancer and anti-infective compounds.
...
Evidence
Lacking for Special Diets in Autism 3:21 AM 1/4/2010
New York Times
An expert panel says digestive problems aren't more common in children with
autism and special diets don't work.
...
Abbott's
purchases bolster future 8:01 AM 1/3/2010
Chicago Tribune
Abbott Laboratories' $7 billion acquisition of the pharmaceutical unit of
Belgian conglomerate Solvay SA gives it complete control over its TriCor cholesterol drug franchise.
...
Biodel
submits NDA for diabetes drug to FDA 6:21 PM 12/30/2009
Reuters
Biodel Inc said it submitted a new drug application to the US FDA for its experimental
diabetes drug VIAject.
...
Valeant
Pharmaceuticals' Retigabine Accepted For FDA Review 8:23 AM 12/30/2009
Wall Street Journal
Valeant Pharmaceuticals International said the US FDA
accepted for review its investigational retigabine to treat adult epilespy patients with partial-onset
seizures.
...
Basilea
Suffers Antibiotic Setback 6:11 AM 12/30/2009
Wall
Street Journal
The US FDA told Basilea Pharmaceutica AG that its key broad-spectrum antibiotic
ceftobiprole can't be approved in its current form.
...
Pfizer
ends trial of lung cancer drug candidate 6:38 PM 12/29/2009
BusinessWeek
Pfizer stopped a late stage clinical trial of figitumumab as a
treatment for non-adenocarcinoma non-small cell lung cancer.
...
Vivus
files marketing application for obesity drug 6:44 AM 12/29/2009
Reuters
Vivus Inc filed for marketing approval for its weight-loss drug Qnexa
which has shown positive results treating obese patients with hypertension, diabetes, and dyslipidemia.
...
Filling
a hole in Medicare drug coverage 7:05 AM 12/28/2009
Washington Post
Democrats have agreed to gradually fill the doughnut hole gap in Medicare
prescription drug coverage. Taking 10 years, today's Medicare patients will face a slightly bigger gap.
...
<- Day Earlier | Today's News
|
